Even if the sensitivity of Flortaucipir for non-AD tauopathies has been questioned, elevated tracer retention compared to controls has been found in areas with non-Alzheimer tau pathology at autopsy [42]. This evidence concerns the gene MAPT and Alzheimer disease.